Tag: haemodialysis

dialysis access

Drug-coated balloons: A “first-line” treatment for stenosis and vascular access failure...

This advertorial is sponsored by Cardionovum® Matteo Tozzi (Varese, Italy) recently spoke to Vascular News about the role of drug-coated balloons (DCBs) in vascular access. The...

Xeltis receives IDE approval from US FDA for haemodialysis vascular access...

Xeltis has announced that it has gained approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) submission to...

WRAPSODY arteriovenous access efficacy (WAVE) pivotal study completes enrolment

Merit Medical has announced that is has completed enrolment in its WRAPSODY arteriovenous access efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective,...
haemodialysis

Pathfinder Medical and Imperial College London awarded Innovate UK Smart grant...

Pathfinder Medical has been awarded a Smart grant for a £1.1 million (US$1.4 million) project by Innovate UK, the UK's innovation agency. A press...
Ukraine

Human-tissue engineered blood vessels remain durable at six years in PAD...

Mid-term results from a phase II study of surgical bypass using the Human Acellular Vessel (HAV; Humacyte) demonstrated an overall secondary patency rate at...

Lydus Medical announces US FDA clearance of microvascular anastomosis aid device

Lydus Medical is pleased to announce that the Vesseal has received US Food and Drug Administration (FDA) 510(k) clearance. The Vesseal is a microvascular...
top 10

Vascular News’ top 10 most popular stories of November 2022

November's top 10 includes the first results from BEST-CLI, as well as new data presented at this year's Vascular Interventional Advances (VIVA; 31 October–3...
haemodialysis

Arteriovenous graft use linked to venous thromboembolism risk in haemodialysis patients

In an observational cohort study of Medicare beneficiaries receiving haemodialysis, the use of an arteriovenous graft (AVG) compared with an arteriovenous fistula (AVF) was...
Vascular Therapies

Vascular Therapies initiates enrolment in ACCESS 2 clinical trial

Vascular Therapies has announced that the first patient in the ACCESS 2 clinical trial was enrolled by Nikhil Kansal at Harbor-UCLA Medical Center in Torrance, USA. The...
top 10

Vascular News’ top 10 most popular stories of July 2022

July's top 10 most popular items include more from this year's Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM 2022; 15–18 June, Boston,...

Intraoperative vascular mapping during haemodialysis access “should be incorporated into routine...

Intraoperative ultrasonographic venous mapping is a useful tool to evaluate vessel suitability for arteriovenous fistula (AVF) creation, Yana Etkin (Zucker School of Medicine at...

First patient enrolled in Merit Medical’s WRAPSODY registry study

Merit Medical has announced the successful enrolment of the first patient in its WRAP registry study in a press release. This study will evaluate...
Flex Vessel Prep

VentureMed completes enrolment of Flex Vessel Prep system randomised controlled trial...

VentureMed Group recently announced that it has completed enrolment of a randomised controlled trial (RCT) titled 'Flex Vessel Prep prior to PTA for the...
Humacyte

Humacyte announces publication of positive long-term follow-up data from phase 2...

Humacyte today announced that five-year data from a phase 2 clinical trial of patients receiving the investigational Human Acellular Vessel (HAV) for arteriovenous (AV)...

New survey finds one third of UK dialysis patients still not...

Quanta Dialysis Technologies announced today the results of the UK Dialysis Patient Experience Survey, showing the wide variance in care experienced by UK dialysis...

Bluegrass Vascular announces Medicare decision to assign New Technology Ambulatory Payment...

Bluegrass Vascular Technologies (Bluegrass Vascular) announced today that the Centers for Medicare & Medicaid Services (CMS) has finalised a new Healthcare Common Procedure Coding...
dialysis

DCBs favoured over PTA for treatment of dysfunctional haemodialysis venous access

A patient-level meta-analysis of randomised controlled trials (RCTs) has shown that drug-coated balloons (DCBs) were “consistently favoured” over percutaneous transluminal angioplasty (PTA) to prolong...
amplifi vein dilation system

Artio Medical completes enrolment of first-in-human trial investigating Amplifi vein dilation...

Artio Medical announced today it has completed enrolment in its first-in-human study evaluating the Amplifi vein dilation system. In the study, five patients were treated...
dialysis

Arteriovenous fistulas contribute to higher survival of haemodialysis patients with COVID-19

A new study, published online in The Journal of Vascular Access (JVA), suggests that arteriovenous fistulas (AVFs) contribute to higher survival of haemodialysis patients...
top 10

Vascular News’ top 10 most popular stories of May 2021

Expanding eligibility for endovascular aneurysm repair (EVAR), new tools for chronic limb-threatening ischaemia (CLTI), and promising data for arteriovenous (AV) fistula remote monitoring all...
haemodialysis

Study supports tunnelled haemodialysis catheter use for permanent dialysis access

In a recent study, Victor Demaerel (University Hospitals Leuven, Leuven, Belgium) and colleagues found that tunnelled haemodialysis catheter (THC) survival in 352 patients was...

Vascular Therapies announces clinical results from phase 3 randomised multicentre clinical...

Vascular Therapies recently announced results from its phase 3 clinical trial in which Sirogen showed encouraging arteriovenous fistula (AVF) outcomes in elderly end-stage renal...

BD announces enrolment in postmarket studies of the WavelinQ endoAVF system

BD announced today that enrolment has begun and the first patients have been treated in the postmarket surveillance study, CONNECT-AV. CONNECT-AV is a prospective, single-arm,...
top 10

Vascular News’ top 10 most popular stories of March 2021

Newly-published data on the benefits of a dedicated vascular limb salvage clinic, key product launches in the vascular access space, and evidence to suggest...
Medtronic IN.PACT AV

Medtronic launches IN.PACT AV DCB in Japan for patients undergoing haemodialysis

Medtronic has announced the launch of IN.PACT AV drug-coated balloon (DCB) in Japan. IN.PACT AV DCB is indicated for the treatment of obstructive lesions...

PatenSee initiates first-in-human trial with its contactless imaging surveillance system for...

PatenSee has initiated a first-in-human clinical trial to assess its machine vision-based surveillance system, a press release from the company reveals. The trial, led...
patency

New standardised reporting system suggests arteriovenous graft infections may be less...

“Using an objective system that discriminates between aetiology and outcome allows a more complete, objective understanding of relative infection risks and outcomes for arteriovenous...

Transit Scientific announces close of its Series A financing round

Transit Scientific has announced the close of its Series A financing round. The round was led by a large multinational investor and joined by...
Biotronik

BIOLUX AV trial demonstrates safety and efficacy of Passeo-18 Lux DCB...

Recent data from the investigator-initiated, randomised controlled trial (RCT), BIOLUX AV, showed that the treatment of dysfunctional haemodialysis access with Biotronik's Passeo-18 Lux drug-coated...
natural

Alucent Biomedical adds to scientific advisory board, expands portfolio with AF...

Alucent Biomedical has announced Stanford vascular surgeon Venita Chandra (Stanford University Medical Center, Stanford, USA) will join the company’s scientific advisory board. The news...
patency

COVID-related hypercoagulability linked to elevated malfunction rate in temporary haemodialysis catheters

Hypercoagulability in COVID-19 patients leads to an increase in the malfunction rate of temporary haemodialysis catheters—but heparin locking of the catheters is linked to...
dialysis

Risk of ischaemic steal syndrome and patency rate comparable for tapered...

In their recent systematic review and meta-analysis, Venkata Sai Jasty (University of Arizona, Tuscon, USA) and colleagues found that the risk of ischaemic steal...
MedAlliance SELUTION SLR

ISABELLA trial for the treatment of failing AV fistulas in haemodialysis...

MedAlliance has announced completion of patient enrolment in the ISABELLA clinical trial with the Selution SLR 018 drug-eluting balloon (DEB) for the treatment of...
patency

Older age and diabetes mellitus identified as risk factors for poor...

Different risk factors affect patency between vascular access construction and the first percutaneous transluminal angioplasty, Mahoko Yoshida (Hiroshima University Hospital, Hiroshima, Japan) and colleagues...
Artio Medical

Artio Medical acquires Flow Forward Medical, expanding their peripheral vascular portfolio

Artio Medical today announced it has acquired Flow Forward Medical, a medical device company developing methods for establishing and maintaining vascular access sites. This...

LeMaitre Vascular acquires Artegraft

LeMaitre Vascular recently announced that it has acquired the business and assets of Artegraft for US$90 million. Under the terms of the deal, LeMaitre will...
VasQ external support

VasQ external support awarded breakthrough device designation by the FDA

The US Food and Drug Administration (FDA) has designated Laminate Medical’s VasQ external support for the creation of arteriovenous fistulas (AVF) in haemodialysis patients...
SAVE-US

Bluegrass Vascular Technologies announces first US commercial cases with the Surfacer...

Bluegrass Vascular Technologies has announced that the first US commercial cases using the Surfacer Inside-Out access catheter system were completed at Santa Clara Valley...
Fist Assist device

Fist Assist announces CE mark and European launch

Fist Assist Devices has received CE mark and has begun marketing the Fist Assist device for vein enhancement and enlargement in the European Union...
Panel at LINC Tuesday MEDTRONIC

LINC 2020: One year IN.PACT AV results show sustained patency benefit...

NOTE: This video is ONLY available to watch in selected countries and geographies  The one-year IN.PACT AV trial results, first presented at LINC 2020 (28–31 January, Leipzig,...

IVUS during haemodialysis access “aids device selection and adequacy of treatment”

Narayan Karunanithy outlines the benefits of intravascular ultrasound (IVUS) during haemodialysis access intervention. Thoracic central veins include intra-thoracic segments of the internal jugular, subclavian, brachiocephalic...
SonieVie

Kidney patients report positive experiences with novel approach to dialysis access

A new study reports high levels of patient satisfaction with a minimally invasive approach to creating vascular access for kidney patients who require haemodialysis....

Merit Medical receives FDA breakthrough device designation for WRAPSODY endovascular stent...

Merit Medical Systems recently announced that it has been granted Breakthrough Device Designation by the US Food and Drug Administration (FDA) for the Merit...

Pursuit Vascular gets CE mark for ClearGuard HD haemodialysis catheter caps

Pursuit Vascular, Inc., manufacturer of ClearGuard HD Antimicrobial Barrier Caps, has announced that the company has received both (CE) Mark and Medical Device Single...

Comparing and contrasting surgically-created AVFs with those made by endovascular means

 Nicholas Inston (Birmingham, UK) tells Vascular News at LINC 2019 about the exciting field of percutaneous arteriovenous fistula (AVF) creation, the main devices and...

Japanese study investigates new device for accurate haemodialysis catheter placement

Researchers at Okayama University report in The Journal of Vascular Access the use of a supporting device for accurately placing haemodialysis catheters in dialysis...

FDA approves Ellipsys Vascular Access System for non-surgical dialysis fistula creation

Ellipsys Vascular Access System (Avenu Medical) has been granted De Novo marketing authorisation from the Food and Drug Administration (FDA). Ellipsys is a minimally-invasive...

everlinQ endoAVF receives FDA de novo marketing approval

everlinQ endoAVF System (TVA Medical) is now approved by the US Food and Drug Administration for de novo marketing. This innovative, minimally invasive technology...

Humacyte appoints Jeffrey Lawson as president and CEO

Humacyte, an innovator in biotechnology and regenerative medicine, has announced that Jeffrey Lawson has been appointed president and chief executive officer. The former chairman...

New data on quality of life and cost savings for everlinQ...

A recent healthcare analysis shows that a novel, catheter-based endovascular system for creating haemodialysis access offers quality-of-life benefits and cost savings compared to the...
endoAVF

Meta-analysis shows positive experience for endoAVF patients for haemodialysis access

An international meta-analysis of clinical experience in patients who received an endovascular arteriovenous fistula (endoAVF) for haemodialysis access was presented at Leipzig Interventional Course...
VasQ

First patients enrolled in US pivotal trial of the VasQ device

The first patients have been enrolled in the US FDA pivotal study of VasQ (Laminate Medical Technologies), an implanted blood vessel external support device...
SAVE-US trial

Bluegrass Vascular announces strategic relationship with Merit Medical

Bluegrass Vascular Technologies is entering into a strategic relationship with Merit Medical Systems. The agreement will streamline European distribution of the recently CE mark-approved Surfacer Inside-Out...
Fist Assist device

Promising results with novel external pneumatic device for fistula maturation

Renal failure affects millions of patients worldwide, with many renal failure patients progressing to end-stage renal disease, requiring dialysis treatment. Dialysis options include central...

Mechanical approaches to improving AV fistula outcomes

Although arteriovenous (AV) fistulae are considered the gold standard for vascular access for haemodialysis and have a low rate of complications and improved longevity...

Tunneled cuffed dialysis catheters: Why does the catheter’s tip matter?

A tunneled catheter remains the most common access in patients initiating haemodialysis.1 This is most likely because the catheters are ready to use immediately...

Flow Forward reports Arteriovenous Fistula Eligibility system data

Flow Forward Medical has announced the completion of a preclinical study and a computational fluid dynamics study supporting continued development of the company's Arteriovenous...

New developments in dialysis grafts

With the rising incidence of haemodialysis worldwide, there is an ever-increasing need for creative, durable means of access. The National Kidney Foundation and Centers...
patency

Vascular Flow announces new haemodialysis access study

The trial is is designed to test the hypothesis that restoring the natural spiral blood flow pattern will increase arteriovenous graft patency in patients undergoing haemodialysis, resulting in fewer interventions.